loadpatents
name:-0.021598815917969
name:-0.012293100357056
name:-0.017621994018555
Zapf; Christoph Wolfgang Patent Filings

Zapf; Christoph Wolfgang

Patent Applications and Registrations

Patent applications and USPTO patent grants for Zapf; Christoph Wolfgang.The latest application filed is for "pyrrolopyrimidines as cftr potentiators".

Company Profile
20.14.25
  • Zapf; Christoph Wolfgang - Oakland CA
  • Zapf; Christoph Wolfgang - Marlborough MA
  • Zapf; Christoph Wolfgang - San Francisco CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Pyrrolopyrimidines as CFTR Potentiators
App 20210171534 - Strohbach; Joseph Walter ;   et al.
2021-06-10
Bruton's Tyrosine Kinase Inhibitors
App 20210002251 - Springer; John Robert ;   et al.
2021-01-07
Bicyclic-Fused Heteroaryl or Aryl Compounds
App 20200377511 - Trzupek; John David ;   et al.
2020-12-03
Bruton's tyrosine kinase inhibitors
Grant 10,815,213 - Springer , et al. October 27, 2
2020-10-27
Bicyclic-fused heteroaryl or aryl compounds
Grant 10,793,579 - Trzupek , et al. October 6, 2
2020-10-06
Bicyclic heteroaryl derivatives as CFTR potentiators
Grant 10,766,904 - Strohbach , et al. Sep
2020-09-08
Rorc2 Inhibitors And Methods Of Use Thereof
App 20200039960 - Schnute; Mark Edward ;   et al.
2020-02-06
Pyrrolopyrimidines As Cftr Potentiators
App 20200017512 - Strohbach; Joseph Walter ;   et al.
2020-01-16
Pyrrolopyrimidines as CFTR potentiators
Grant 10,494,374 - Strohbach , et al. De
2019-12-03
Bicyclic Heteroaryl Derivatives As Cftr Potentiators
App 20190330219 - Strohbach; Joseph Walter ;   et al.
2019-10-31
Bicyclic-Fused Heteroaryl or Aryl Compounds
App 20190270751 - Trzupek; John David ;   et al.
2019-09-05
Bicyclic heteroaryl derivatives as CFTR potentiators
Grant 10,377,762 - Strohbach , et al. A
2019-08-13
Pyrrolopyrimidines As Cftr Potentiators
App 20190225621 - Strohbach; Joseph Walter ;   et al.
2019-07-25
Bruton's Tyrosine Kinase Inhibitors
App 20190202798 - Springer; John Robert ;   et al.
2019-07-04
Bicyclic-fused heteroaryl or aryl compounds
Grant 10,329,302 - Trzupek , et al.
2019-06-25
Bicyclic-fused heteroaryl or aryl compounds as IRAK4 modulators
Grant 10,316,018 - Lee , et al.
2019-06-11
Pyrrolopyrimidines as CFTR potentiators
Grant 10,301,315 - Strohbach , et al.
2019-05-28
Rorc2 Inhibitors And Methods Of Use Thereof
App 20190144429 - Schnute; Mark Edward ;   et al.
2019-05-16
Bruton's tyrosine kinase inhibitors
Grant 10,266,513 - Springer , et al.
2019-04-23
Bicyclic-fused Heteroaryl Or Aryl Compounds As Irak4 Modulators
App 20190092750 - LEE; KATHERINE LIN ;   et al.
2019-03-28
Bicyclic heteroaryl derivatives as CFTR potentiators
Grant 10,208,053 - Strohbach , et al. Feb
2019-02-19
Bicyclic Heteroaryl Derivatives As Cftr Potentiators
App 20190016727 - Strohbach; Joseph Walter ;   et al.
2019-01-17
Bicyclic Heteroaryl Derivatives As Cftr Potentiators
App 20190016728 - Strohbach; Joseph Walter ;   et al.
2019-01-17
Bicyclic-fused heteroaryl or aryl compounds as IRAK4 modulators
Grant 10,174,000 - Lee , et al. J
2019-01-08
Bicyclic heteroaryl derivatives as CFTR potentiators
Grant 10,131,670 - Strohbach , et al. November 20, 2
2018-11-20
Rorc2 Inhibitors And Methods Of Use Thereof
App 20180282304 - Schnute; Mark Edward ;   et al.
2018-10-04
Bicyclic-fused Heteroaryl Or Aryl Compounds As Irak4 Modulators
App 20180244646 - LEE; KATHERINE LIN ;   et al.
2018-08-30
Bicyclic Heteroaryl Derivatives As Cftr Potentiators
App 20180170938 - Strohbach; Joseph Walter ;   et al.
2018-06-21
Pyrrolopyrimidines As Cftr Potentiators
App 20180141954 - Strohbach; Joseph Walter ;   et al.
2018-05-24
Bicyclic-Fused Heteroaryl or Aryl Compounds
App 20180127432 - Trzupek; John David ;   et al.
2018-05-10
Rorc2 Inhibitors And Methods Of Use Thereof
App 20180086736 - Schnute; Mark Edward ;   et al.
2018-03-29
Bicyclic-fused heteroaryl or aryl compounds
Grant 9,879,022 - Trzupek , et al. January 30, 2
2018-01-30
Bruton's Tyrosine Kinase Inhibitors
App 20170283393 - Springer; John Robert ;   et al.
2017-10-05
Rorc2 Inhibitors And Methods Of Use Thereof
App 20170233371 - Schnute; Mark Edward ;   et al.
2017-08-17
Bicyclic-Fused Heteroaryl or Aryl Compounds
App 20160347760 - Trzupek; John David ;   et al.
2016-12-01
Bicyclic-fused heteroaryl or aryl compounds
Grant 9,458,168 - Trzupek , et al. October 4, 2
2016-10-04
Rorc2 Inhibitors And Methods Of Use Thereof
App 20160046597 - Schnute; Mark Edward ;   et al.
2016-02-18
Bruton's Tyrosine Kinase Inhibitors
App 20150291554 - Springer; John Robert ;   et al.
2015-10-15
Bicyclic-Fused Heteroaryl or Aryl Compounds
App 20150284405 - Trzupek; John David ;   et al.
2015-10-08

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed